CLINICAL_TRIALS ClinicalTrials.gov record update

Ivosidenib Combined With Venetoclax and Azacitidine for the Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia: a Prospective, Single-arm, Two-cohorts, Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07007949
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:42.696378+00:00
Published At: 2025-06-06T00:00:00+00:00
Record Updated At: 2025-06-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Myeloid Leukemia", "IDH1 Gene Mutation", "Ivosidenib"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-06-06"
protocolSection.identificationModule.nctId: "NCT07007949"
protocolSection.identificationModule.officialTitle: "Ivosidenib Combined With Venetoclax and Azacitidine for the Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia: a Prospective, Single-arm, Two-cohorts, Study"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.